Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways. - Kheraldine, Hadeel; Gupta, Ishita; Cyprian, Farhan Sachal; Vranic, Semir; Al-Farsi, Halema F.; Merhi, Maysaloun; Dermime, Said; Al Moustafa, Ala-Eddin (Cancer Cell International, 2024)